StonvexLoading…
StonvexStonvexStonvexCore line items from IQST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $97.92M | $316.90M | $232.68M | $129.82M |
Operating Income | $-958.01K | $-4.25M | $-1.82M | $-1.26M |
Net Income | $-1.39M | $-8.51M | $-5.82M | $-2.35M |
EPS (Diluted) | $-0.29 | $-2.86 | $-1.97 | $-1.28 |
Total Assets | $44.53M | $51.09M | $46.89M | $51.41M |
Total Liabilities | $30.23M | $34.81M | $29.03M | $37.12M |
Cash & Equivalents | $2.60M | $2.16M | $2.26M | $2.04M |
Free Cash Flow OCF − CapEx | $-176.85K | $-3.96M | $-2.71M | $-1.74M |
Shares Outstanding | 5.08M | 4.67M | 3.83M | 3.50M |